Effects of Multiple-Dose Ponesimod on the Pharmacokinetics of a Single Dose of Ortho-Novum®1/35 in Healthy Female Subjects.

Trial Profile

Effects of Multiple-Dose Ponesimod on the Pharmacokinetics of a Single Dose of Ortho-Novum®1/35 in Healthy Female Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Mar 2013

At a glance

  • Drugs Ponesimod (Primary) ; Ethinylestradiol/norethisterone
  • Indications Multiple sclerosis; Plaque psoriasis; Pregnancy
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Actelion Pharmaceuticals
  • Most Recent Events

    • 25 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top